Amgen Inc Earnings Estimates
AMGNNASDAQ
Amgen Earnings Estimates, EPS & Revenue | NASDAQ:AMGN
Amgen (AMGN) is scheduled to report Q2 earnings on August 4, 2026. Analysts estimate EPS of $5.58 and quarterly revenue of $9.42B.
In the most recent quarter (Q1), Amgen reported EPS of $5.15, beating estimates of $4.76 by 0.08%. Revenue came in at $8.62B, exceeding the estimate of $8.55B by 0.01%.
Amgen has beaten EPS estimates in 7 consecutive quarters.
Over the last 4 quarters, Amgen has averaged an EPS surprise of 0.12% and a revenue surprise of 0.04%.
Earnings Date
Aug 4
EPS Estimate
$5.580
Quarterly Revenue Estimate
$9.42B
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$37.22B
Amgen Earnings History
Analyze the earnings history of Amgen using advanced sorting and filters.
Loading calendar...
Amgen (AMGN) Earnings Per Share
The chart below shows Amgen's reported EPS compared to analyst estimates over recent quarters.
Amgen (AMGN) Revenue
The chart below shows Amgen's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Amgen (NASDAQ:AMGN) reporting earnings?
Amgen (AMGN) is scheduled to report earnings on August 4, 2026. The last reported earnings were for reported on April 30, 2026 for Q1.
What were the latest earnings per share (EPS) for Amgen (NASDAQ:AMGN)?
The Actual EPS was $5.15, which beat the estimate of $4.76.
What were Amgen’s (NASDAQ:AMGN) revenues?
The Actual Revenue was $8.62B, which beat the estimate of $8.55B.
